Clinical

Dataset Information

Pharmacogenomic study of modified FOLFOX6 (combination chemotherapy of Oxaliplatin with infusional 5-FU/l-Leucovorin) in colorectal cancer


ABSTRACT: Interventions: Intravenous administration of l-Leucovorin 175 mg/body, Oxaliplatin 85 mg/m2 as a 2-hour infusion followed by bolus 5-FU 400 mg/m2 and 46hr infusion 5-FU 2,400 mg/m2 every two weeks Primary outcome(s): Response rate(best tumor shrinkage(rate)) Study Design: Single arm Non-randomized

DISEASE(S): Chemotherapy-na&iuml,Ve Stage Iv Colorectal Cancer After Palliative Operation

PROVIDER: 2609819 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR